156 related articles for article (PubMed ID: 33469374)
1. Impact of Primary Site Surgery on Survival of Patients with de novo Stage IV Breast Cancer.
Huang Z; Tan Q; Qin Q; Mo Q; Wei C
Cancer Manag Res; 2021; 13():319-327. PubMed ID: 33469374
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
Rossi V; Nolè F; Redana S; Adamoli L; Martinello R; Aurilio G; Verri E; Sapino A; Viale G; Aglietta M; Montemurro F
Breast; 2014 Feb; 23(1):44-9. PubMed ID: 24210572
[TBL] [Abstract][Full Text] [Related]
3. Metastatic pattern discriminates survival benefit of primary surgery for de novo stage IV breast cancer: A real-world observational study.
Wang K; Shi Y; Li ZY; Xiao YL; Li J; Zhang X; Li HY
Eur J Surg Oncol; 2019 Aug; 45(8):1364-1372. PubMed ID: 30837102
[TBL] [Abstract][Full Text] [Related]
4. Survival Benefit of Surgical Removal of Primary Tumor in Patients With Stage IV Breast Cancer.
Kim HJ; Kang E; Kim JH; Kim SH; Kim YJ; Kim IA; Eom KY; Chae SM; Kang KM; Kim EK; Kim SW
Clin Breast Cancer; 2018 Oct; 18(5):e1037-e1044. PubMed ID: 29909259
[TBL] [Abstract][Full Text] [Related]
5. Association of surgery with improved survival in stage IV breast cancer patients.
Blanchard DK; Shetty PB; Hilsenbeck SG; Elledge RM
Ann Surg; 2008 May; 247(5):732-8. PubMed ID: 18438108
[TBL] [Abstract][Full Text] [Related]
6. Metastatic Pattern Discriminates Survival Benefit of Type of Surgery in Patients With
Li K; Zhou C; Yu Y; Niu L; Zhang W; Wang B; He J; Ge G
Front Surg; 2021; 8():696628. PubMed ID: 34805256
[No Abstract] [Full Text] [Related]
7. Primary site surgery of de novo stage IV HER2-positive breast cancer in the era of new drug treatments.
Lu G; Jia L; Yang R; Liu Y; Lv Z; Cui J
Front Oncol; 2023; 13():1308854. PubMed ID: 38264738
[TBL] [Abstract][Full Text] [Related]
8. Hormone receptor status may impact the survival benefit of surgery in stage iv breast cancer: a population-based study.
Tan Y; Li X; Chen H; Hu Y; Jiang M; Fu J; Yuan Y; Ding K
Oncotarget; 2016 Oct; 7(43):70991-71000. PubMed ID: 27542240
[TBL] [Abstract][Full Text] [Related]
9. Role of locoregional surgery in patients with de novo stage IV breast cancer: analysis of real-world data from China.
Ma L; Mi Y; Cui S; Wang H; Fu P; Yin Y; Jin F; Li J; Liu Y; Fan Z; Zhang H; Geng C; Jiang Z
Sci Rep; 2020 Oct; 10(1):18132. PubMed ID: 33093581
[TBL] [Abstract][Full Text] [Related]
10. Could local surgery improve survival in de novo stage IV breast cancer?
Xiong Z; Deng G; Wang J; Li X; Xie X; Shuang Z; Wang X
BMC Cancer; 2018 Sep; 18(1):885. PubMed ID: 30200932
[TBL] [Abstract][Full Text] [Related]
11. The impact of surgical excision of the primary tumor in stage IV breast cancer on survival: a meta-analysis.
Lu S; Wu J; Fang Y; Wang W; Zong Y; Chen X; Huang O; He JR; Chen W; Li Y; Shen K; Zhu L
Oncotarget; 2018 Feb; 9(14):11816-11823. PubMed ID: 29545938
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2-Targeted Therapy.
Wong Y; Raghavendra AS; Hatzis C; Irizarry JP; Vega T; Horowitz N; Barcenas CH; Chavez-MacGregor M; Valero V; Tripathy D; Pusztai L; Murthy RK
Oncologist; 2019 Mar; 24(3):313-318. PubMed ID: 30139836
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy for primary tumor of
Yoshimura M
Transl Cancer Res; 2020 Aug; 9(8):5108-5116. PubMed ID: 35117877
[TBL] [Abstract][Full Text] [Related]
14. Impact of Locoregional Treatment on Prognosis of de novo Stage IV Breast Cancer: A Retrospective Long-Term Study of Chinese Population.
Wang W; Liu J; Wang J; Gao J; Wang X; Wang X
Gynecol Obstet Invest; 2019; 84(3):248-258. PubMed ID: 30448829
[TBL] [Abstract][Full Text] [Related]
15. Survival differences among women with de novo stage IV and relapsed breast cancer.
Dawood S; Broglio K; Ensor J; Hortobagyi GN; Giordano SH
Ann Oncol; 2010 Nov; 21(11):2169-2174. PubMed ID: 20427349
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.
Gu Y; Wu G; Zou X; Huang P; Yi L
Med Sci Monit; 2020 Feb; 26():e920432. PubMed ID: 32043484
[TBL] [Abstract][Full Text] [Related]
17. De-novo metastatic breast cancers with or without primary tumor resection - A 10-year study.
Co M; Ng J; Kwong A
Cancer Treat Res Commun; 2019; 19():100118. PubMed ID: 30825858
[TBL] [Abstract][Full Text] [Related]
18. Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective.
Choi SH; Kim JW; Choi J; Sohn J; Kim SI; Park S; Park HS; Jeong J; Suh CO; Keum KC; Kim YB; Lee IJ
Clin Breast Cancer; 2018 Apr; 18(2):e167-e178. PubMed ID: 28689012
[TBL] [Abstract][Full Text] [Related]
19. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis.
Fields RC; Jeffe DB; Trinkaus K; Zhang Q; Arthur C; Aft R; Dietz JR; Eberlein TJ; Gillanders WE; Margenthaler JA
Ann Surg Oncol; 2007 Dec; 14(12):3345-51. PubMed ID: 17687611
[TBL] [Abstract][Full Text] [Related]
20. Metastasectomy versus radiation of secondary sites in stage IV breast cancer: Analysis from a national cancer registry.
Bilani N; Yaghi M; Main O; Naik M; Jabbal I; Rivera C; Elson L; Liang H; Saravia D; Nahleh Z
Breast; 2021 Dec; 60():185-191. PubMed ID: 34673385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]